株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

血液腫瘍:世界の治験レビュー

Hematological Tumor Global Clinical Trials Review, H1, 2015

発行 GlobalData 商品コード 242652
出版日 ページ情報 英文 102 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
血液腫瘍:世界の治験レビュー Hematological Tumor Global Clinical Trials Review, H1, 2015
出版日: 2015年03月16日 ページ情報: 英文 102 Pages
概要

当レポートでは、世界の血液腫瘍治療薬の臨床試験について調査し、地域別の臨床試験数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断 (一時中止、廃止、打ち切り) された試験のリストなどを提供しています。

目次

  • イントロダクション
  • 血液腫瘍
  • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
  • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
  • 臨床試験に寄与している主要5ヵ国 − 欧州
  • 臨床試験に寄与している主要国 − 北米
  • 臨床試験に寄与している主要国 − 中東およびアフリカ
  • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 G7 諸国:がん臨床試験の血液腫瘍比率
  • 臨床試験 G7 諸国:位相別
  • 臨床試験 G7 諸国:治験ステータス別
  • 臨床試験 E7 諸国:がん臨床試験の血液腫瘍比率
  • 臨床試験 E7 諸国:位相別
  • 臨床試験 E7 諸国:治験ステータス別
  • 相別臨床試験
  • 進行中の治験:位相別
  • 臨床試験:治験ステータス別
  • 臨床試験:エンドポイントステータス別
  • 未完了の治験:血液腫瘍
  • 期間ごとの被験者数
  • 臨床試験:スポンサータイプ別
  • 有力なスポンサー
  • 主な臨床試験参加企業
  • 有望な治療薬
  • 臨床試験プロファイル
  • 臨床試験概要: 主要企業 / 研究機関 / 大学
  • Novartis AG
  • GlaxoSmithKline plc
  • Sanofi
  • Pfizer Inc.
  • AstraZeneca PLC
  • Amgen Inc.
  • 武田薬品工業
  • Bellicum Pharmaceuticals, Inc.
  • National Cancer Institute
  • University of Texas M. D. Anderson Cancer Center
  • Fred Hutchinson Cancer Research Center
  • Roswell Park Cancer Institute
  • Thomas Jefferson University
  • Baylor College of Medicine
  • Memorial Sloan Kettering Cancer Center
  • Masonic Cancer Center
  • National Cancer Center Hospital
  • University of California, San Francisco

付録

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2581CTIDB

GlobalData's clinical trial report, "Hematological Tumor Global Clinical Trials Review, H1, 2015" provides data on the Hematological Tumor clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hematological Tumor. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hematological Tumor. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hematological Tumor
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hematological Tumor to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hematological Tumor
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hematological Tumor Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Infinity Pharmaceuticals, Inc.
      • Clinical Trial Overview of Infinity Pharmaceuticals, Inc.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Bellicum Pharmaceuticals, Inc.
      • Clinical Trial Overview of Bellicum Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of University of Texas M. D. Anderson Cancer Center
      • Fred Hutchinson Cancer Research Center
      • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
      • Roswell Park Cancer Institute
      • Clinical Trial Overview of Roswell Park Cancer Institute
      • Thomas Jefferson University
      • Clinical Trial Overview of Thomas Jefferson University
      • Baylor College of Medicine
      • Clinical Trial Overview of Baylor College of Medicine
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Masonic Cancer Center
      • Clinical Trial Overview of Masonic Cancer Center
      • National Cancer Center Hospital
      • Clinical Trial Overview of National Cancer Center Hospital
      • University of California, San Francisco
      • Clinical Trial Overview of University of California, San Francisco
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hematological Tumor Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hematological Tumor Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Hematological Tumor Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hematological Tumor Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Infinity Pharmaceuticals, Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Bellicum Pharmaceuticals, Inc., 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Texas M. D. Anderson Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Center Hospital, 2015*
  • Hematological Tumor Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2015*

List of Figures

  • Hematological Tumor Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, G7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hematological Tumor to Oncology Clinical Trials, E7 Countries (%), 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hematological Tumor Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hematological Tumor Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hematological Tumor Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hematological Tumor Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top